Therapeutic Advances in Gastroenterology
Open Access Publication
Rights and Permissions
Lee C, Louie T, Bancke L, Guthmueller B, Harvey A, Feuerstadt P, Khanna S, Orenstein R, Dubberke ER. Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials. Therap Adv Gastroenterol. 2023 Jun 12;16:17562848231174277. doi: 10.1177/17562848231174277.
© The Author(s), 2023.
Creative Commons License (CC BY-NC 4.0)
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Request permissions for this article.
Lee, Christine; Louie, Thomas; Bancke, Lindy; Guthmueller, Beth; Harvey, Adam; Feuerstadt, Paul; Khanna, Sahil; Orenstein, Robert; and Dubberke, Erik R, "Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: Data from five prospective clinical trials." Therapeutic Advances in Gastroenterology. 16, e17562848231174277 (2023).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.